"A Multicenter, Open Label, Phase 1b Study to Evaluate Safety, Pharmacodynamics and Efficacy of RVP 001 in Adult Patients with Known CNS Lesions and Who Have Undergone GBCA Enhanced MRI"
Clinical Trial Grant
Awarded By
Reveal Pharmaceuticals, Inc.
Start Date
January 15, 2024
End Date
June 1, 2026
Awarded By
Reveal Pharmaceuticals, Inc.
Start Date
January 15, 2024
End Date
June 1, 2026